Singulair may also be an check this out treatment option to low-dose inhaled corticosteroids for 2 to 5 year old patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use, and who have demonstrated that they are not capable of using inhaled corticosteroids see section 4.
Singulair is montelukast 4mg granules sachets sugar free indicated in the prophylaxis of asthma from 2 years of age and older in which the predominant component is exercise-induced bronchoconstriction.
This medicinal product is to be given to a child under adult supervision. The recommended dose for paediatric patients 6 months to 5 years of age is one sachet of 4 mg granules daily to be taken in the evening.
No dosage adjustment within this age group is necessary. Efficacy data from clinical trials in paediatric patients 6 months to 2 years of age with persistent asthma are montelukast 4mg granules sachets sugar free. Patients should be evaluated after 2 to montelukast 4mg granules sachets sugar free weeks montelukast 4mg granules sachets sugar free response to montelukast treatment.
Treatment should be discontinued if a lack of response is observed. The Singulair Paediatric 4 mg granules montelukast 4mg granules sachets sugar free is not recommended below 6 months of age.
Singulair granules can be administered either directly in the mouth, or mixed with a spoonful of cold or room temperature soft food e. The sachet should not be just montelukast 4mg granules sachets sugar free for source until ready to use. After opening the sachet, the full dose of Singulair granules must be administered immediately within 15 minutes. If mixed with food, Singulair granules must not be stored for future use.
Singulair granules just click for source not intended to be dissolved in liquid for administration. However, montelukast 4mg granules sachets sugar free may be taken subsequent to administration.
Singulair granules can be administered without regard to the timing of food ingestion. The therapeutic effect of Singulair on parameters of asthma control occurs within one day. Patients should be advised to continue montelukast 4mg granules sachets sugar free Singulair breastfeeding promethazine hcl if their asthma is under control, as well as during periods of montelukast 4mg granules sachets sugar free asthma.
No dosage adjustment is necessary for patients with renal insufficiency, or mild to moderate hepatic impairment.
There are no data on patients with /prednisolone-acetate-dosage-hplc.html hepatic impairment. The dosage is the same for both male and female patients. Singulair as an alternative treatment option to low-dose inhaled corticosteroids for mild, persistent asthma.
Montelukast is montelukast 4mg granules sachets sugar free recommended as monotherapy in patients with moderate persistent asthma. The use of montelukast as an alternative treatment option granules sachets low-dose inhaled corticosteroids for children 2 to 5 years old with mild persistent asthma should only be considered sugar free patients who do not have a recent history of serious asthma attacks that required oral corticosteroid use and who have demonstrated that they are not capable of using inhaled corticosteroids see section 4.
montelukast 4mg
Mild persistent asthma is defined as asthma symptoms more than once a week but less than once a day, nocturnal symptoms more than twice a month but less than once a week, normal lung function between episodes. If satisfactory montelukast 4mg granules sachets sugar free of asthma is not achieved at follow-up usually within one monththe need for an additional or different anti-inflammatory therapy based on the step system montelukast 4mg granules sachets sugar free asthma therapy should be evaluated.
Patients should be periodically evaluated for their asthma control.
2018 ©